{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:13:37Z","timestamp":1784304817879,"version":"3.55.0"},"reference-count":221,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Epithelial ovarian cancer is predominantly diagnosed at advanced stages which creates significant therapeutic challenges. As a result, the 5-year survival rate is low. Within ovarian cancer, significant tumor heterogeneity exists, and the tumor microenvironment is diverse. Tumor heterogeneity leads to diversity in therapy response within the tumor, which can lead to resistance or recurrence. Advancements in therapy development and tumor profiling have initiated a shift from a \u201cone-size-fits-all\u201d approach towards precision patient-based therapies. Here, we review aspects of ovarian tumor heterogeneity that facilitate tumorigenesis and contribute to treatment failure. These tumor characteristics should be considered when designing novel therapies or characterizing mechanisms of treatment resistance. Individual patients vary considerably in terms of age, fertility and contraceptive use which innately affects the endocrine milieu in the ovary. Similarly, individual tumors differ significantly in their immune profile, which can impact the efficacy of immunotherapies. Tumor size, presence of malignant ascites and vascular density further alters the tumor microenvironment, creating areas of significant hypoxia that is notorious for increasing tumorigenesis, resistance to standard of care therapies and promoting stemness and metastases. We further expand on strategies aimed at improving oxygenation status in tumors to dampen downstream effects of hypoxia and set the stage for better response to therapy.<\/jats:p>","DOI":"10.3389\/fendo.2021.772349","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:22:20Z","timestamp":1637133740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Madison","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Matuszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Petrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1155\/2007\/309382","article-title":"Early Detection of Ovarian Cancer","volume":"23","author":"Badgwell","year":"2007","journal-title":"Dis Markers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and Challenges in Screening for Early Detection of Ovarian Cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","article-title":"Ovarian Cancer Statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd008215.pub3","article-title":"Risk of Ovarian Cancer in Women Treated With Ovarian Stimulating Drugs for Infertility","author":"Rizzuto","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1002893","DOI":"10.1371\/journal.pmed.1002893","article-title":"Appraising the Role of Previously Reported Risk Factors in Epithelial Ovarian Cancer Risk: A Mendelian Randomization Analysis","volume":"16","author":"Yarmolinsky","year":"2019","journal-title":"PloS Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-0618","article-title":"Estrogen Receptor-\u03b2 Expression of Ovarian Tumors and Its Association With Ovarian Cancer Risk Factors","volume":"29","author":"Shafrir","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0492-8","article-title":"Mendelian Randomisation Study of Height and Body Mass Index as Modifiers of Ovarian Cancer Risk in 22,588 BRCA1 and BRCA2 Mutation Carriers","volume":"121","author":"Qian","year":"2019","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.07.010","article-title":"Diagnosis and Treatment of Ovarian Cancer","volume":"32","author":"Orr","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5604\/17322693.1184451","article-title":"Ovarian Cancer \u2013 From Biology to Clinic","volume":"69","author":"Aleksandra Kujawa","year":"2015","journal-title":"Postepy Hig Med Dosw"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.2.0422","article-title":"Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1055-9965.98.14.1","article-title":"Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses","volume":"14","author":"Lukanova","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1702","article-title":"Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia","volume":"64","author":"Stewart","year":"2004","journal-title":"Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2008.12.024","article-title":"Overexpression of Follicle-Stimulating Hormone Receptor Facilitates the Development of Ovarian Epithelial Cancer","volume":"278","author":"Zhang","year":"2009","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-2","article-title":"Human Chorionic Gonadotropin and Its Relation to Grade, Stage and Patient Survival in Ovarian Cancer","volume":"12","author":"Lenhard","year":"2012","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/mt.2012.187","article-title":"Targeting Gonadotropin-Releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-Mesothelial Adhesion","volume":"21","author":"Cheung","year":"2013","journal-title":"Mol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-1-65","article-title":"Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer","volume":"1","author":"Gr\u00fcndker","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e90575","DOI":"10.1371\/journal.pone.0090575","article-title":"Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients","volume":"9","author":"Walentowicz","year":"2014","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.06.017","article-title":"Diagnostic Applications for Inhibin and Activins","volume":"359","author":"McNeilly","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gau074","article-title":"The Inhibin\/Activin Signalling Pathway in Human Gonadal and Adrenal Cancers","volume":"20","author":"Marino","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0175","article-title":"Hormone Response in Ovarian Cancer: Time to Reconsider as a Clinical Target","volume":"19","author":"Modugno","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of Ovarian Cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10696","article-title":"Vecchia C La. Long-Term Effects of Oral Contraceptives on Ovarian Cancer Risk","volume":"102","author":"Bosetti","year":"2002","journal-title":"Int J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.15430\/jcp.2013.18.2.113","article-title":"Protective Effect of Progesterone During Pregnancy Against Ovarian Cancer","volume":"18","author":"Han","year":"2013","journal-title":"J Cancer Prev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2013595117","article-title":"Targeting Progesterone Signaling Prevents Metastatic Ovarian Cancer","volume":"117","author":"Kim","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2771","article-title":"Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1","volume":"93","author":"Peluso","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ygyno.2004.03.026","article-title":"Estrogens and Epithelial Ovarian Cancer","volume":"94","author":"Cunat","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2019.01.015","article-title":"Evidences for Involvement of Estrogen Receptor Induced ERK1\/2 Activation in Ovarian Cancer Cell Proliferation by Cadmium Chloride","volume":"56","author":"Ataei","year":"2019","journal-title":"Toxicol Vitr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.06.056","article-title":"The Expression of Estrogen Receptors as Well as GREB1, C-MYC, and Cyclin D1, Estrogen-Regulated Genes Implicated in Proliferation, Is Increased in Peritoneal Endometriosis","volume":"98","author":"Pellegrini","year":"2012","journal-title":"Fertil Steril"},{"key":"B30","article-title":"Endometriosis and Its Treatment With Danazol or Lupron in Relation to Ovarian Cancer","volume":"9","author":"Cottreau","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B31","article-title":"Down-Regulation of Transforming Growth Factor \u03b2 Receptors by Androgen in Ovarian Cancer Cells","volume":"60","author":"Evangelou","year":"2000","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.8.617","article-title":"Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells","volume":"94","author":"Syed","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1677\/ERC-09-0308","article-title":"FSH Inhibits Ovarian Cancer Cell Apoptosis by Up-Regulating Survivin and Down-Regulating PDCD6 and DR5","volume":"18","author":"Huang","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.26355\/EURREV_201806_15159","article-title":"Expressions and Correlation Analysis of HIF-1\u03b1, Survivin and VEGF in Patients With Hepatocarcinoma","volume":"22","author":"Tian","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0192","article-title":"Transcript and Protein Profiling Identifies Signaling, Growth Arrest, Apoptosis, and NF-\u03bab Survival Signatures Following GNRH Receptor Activation","volume":"20","author":"Meyer","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8392","article-title":"ATX-LPA Axis Facilitates Estrogen-Induced Endometrial Cancer Cell Proliferation via MAPK\/ERK Signaling Pathway","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-021-02003-w","article-title":"Estrogen\/ER in Anti-Tumor Immunity Regulation to Tumor Cell and Tumor Microenvironment","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002029107","article-title":"Gonadotropin-Positive Pituitary Tumors Accompanied by Ovarian Tumors in Aging Female Er\u03b2-\/- Mice","volume":"107","author":"Fan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","article-title":"Prognostic Value of Serum and Ascites Levels of Estradiol, FSH, LH and Prolactin in Ovarian Cancer","volume":"29","author":"Chen","year":"2009","journal-title":"Anticancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.07.008","article-title":"Current Understanding of Molecular and Cellular Mechanisms in Fibroplasia and Angiogenesis During Acute Wound Healing","volume":"72","author":"Greaves","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911423031","article-title":"Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01676-X","article-title":"FGF and VEGF Function in Angiogenesis: Signalling Pathways, Biological Responses and Therapeutic Inhibition","volume":"22","author":"Cross","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ph3030572","article-title":"Platelet-Derived Growth Factor (PDGF)\/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals"},{"key":"B44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in Angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i8.1082","article-title":"Hypoxia-Inducible Factor-1 in Tumour Angiogenesis","volume":"10","author":"Shi","year":"2004","journal-title":"World J Gastroenterol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jth.13978","article-title":"Thrombin-Reduced miR-27b Attenuates Platelet Angiogenic Activities In Vitro via Enhancing Platelet Synthesis of Anti-Angiogenic Thrombospondin-1","volume":"16","author":"Miao","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2015.09.007","article-title":"Endostatin\u2019s Emerging Roles in Angiogenesis, Lymphangiogenesis, Disease, and Clinical Applications","volume":"1850","author":"Walia","year":"2015","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.760660","article-title":"Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation","volume":"292","author":"Lord","year":"2017","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1258\/0007142001903364","article-title":"Angiogenesis and Its Control in the Female Reproductive System","volume":"56","author":"Fraser","year":"2000","journal-title":"Br Med Bull"},{"key":"B50","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/beog.2000.0133","article-title":"Angiogenesis in Ovarian Follicular and Luteal Development","volume":"14","author":"Hazzard","year":"2000","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.2.847","article-title":"Production of a Corpus Luteum Angiogenic Factor Responsible for Proliferation of Capillaries and Neovascularization of the Corpus Luteum","volume":"75","author":"Gospodarowicz","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1095\/biolreprod.114.123711","article-title":"Angiogenesis in the Primate Ovulatory Follicle Is Stimulated by Luteinizing Hormone via Prostaglandin E2","volume":"92","author":"Trau","year":"2015","journal-title":"Biol Reprod"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13203","article-title":"Loss of Ovarian Function Promotes Angiogenesis in Human Ovarian Carcinoma","volume":"94","author":"Schiffenbauer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.1745","article-title":"Luteinizing Hormone Facilitates Angiogenesis in Ovarian Epithelial Tumor Cells and Metformin Inhibits the Effect Through the mTOR Signaling Pathway","volume":"27","author":"Liao","year":"2012","journal-title":"Oncol Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6631","article-title":"Estrogen Enhances Tumor Growth and Angiogenesis Indirectly via Mediation of Bone Marrow-Derived Cells as Well as Directly Through Stimulation of Tumor and Endothelial Cells","volume":"40","author":"Zhuo","year":"2018","journal-title":"Oncol Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24373","article-title":"Estrogen Regulation of Thrombospondin-1 in Human Breast Cancer Cells","volume":"125","author":"Hyder","year":"2009","journal-title":"Int J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00248","article-title":"Unraveling the Role of Angiogenesis in Cancer Ecosystems","volume":"8","author":"Zuazo-Gaztelu","year":"2018","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in Cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc Heal Risk Manag"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1253454","article-title":"Heterogeneity of the Tumor Vasculature","volume":"36","author":"Nagy","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are Tumour Blood Vessels Abnormal and Why Is It Important to Know","volume":"100","author":"Nagy","year":"2009","journal-title":"Br J Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","article-title":"Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors","volume":"160","author":"Morikawa","year":"2002","journal-title":"Am J Pathol"},{"key":"B64","article-title":"Fluctuations in Red Cell Flux in Tumor Microvessels Can Lead to Transient Hypoxia and Reoxygenation in Tumor Parenchyma","volume":"56","author":"Kimura","year":"1996","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells: Identification of a 5\u2019 Enhancer","volume":"77","author":"Liu","year":"1995","journal-title":"Circ Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24601","article-title":"Hypoxia Induces Chemoresistance in Ovarian Cancer Cells by Activation of Signal Transducer and Activator of Transcription 3","volume":"125","author":"Selvendiran","year":"2009","journal-title":"Int J Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13048-018-0388-x","article-title":"Investigation of Hypoxia Networks in Ovarian Cancer via Bioinformatics Analysis","volume":"11","author":"Zhang","year":"2018","journal-title":"J Ovarian Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e0156403","DOI":"10.1371\/journal.pone.0156403","article-title":"The Development of an Angiogenic Protein \u201cSignature\u201d in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling","volume":"11","author":"Trachana","year":"2016","journal-title":"PloS One"},{"key":"B69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the Role of the Tumor Vasculature in Antitumor Immunity and Immunotherapy Article","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"a006536","DOI":"10.1101\/cshperspect.a006536","article-title":"Tumor Endothelial Cells","volume":"2","author":"Dudley","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B71","article-title":"Cancer Invasion and Metastasis\u202f: Molecular and Cellular Perspective Cancer Invasion and Metastasis\u202f: The Role of Cell Adhesion Molecules","volume":"9","author":"Martin","year":"2014","journal-title":"Cancer Invasion Metastasis Mol Cell Perspect"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00952","article-title":"Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1702974","article-title":"Targeting Tumor Interstitial Fluid Pressure: Will It Yield Novel Successful Therapies for Solid Tumors","volume":"23","author":"B\u00f6ckelmann","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10931","article-title":"Functional Intratumoral Lymphatics in Patient-Derived Xenograft Models of Squamous Cell Carcinoma of the Uterine Cervix: Implications for Lymph Node Metastasis","volume":"7","author":"Rofstad","year":"2016","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107092","article-title":"Magnetic Resonance Imaging in an Experimental Model of Human Ovarian Cancer Demonstrating Altered Microvascular Permeability After Inhibition of Vascular Endothelial Growth Factor","volume":"183","author":"Gossmann","year":"2000","journal-title":"Am J Obstetrics Gynecol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00595","article-title":"Ascites Volumes and the Ovarian Cancer Microenvironment","volume":"8","author":"Penet","year":"2018","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25176","article-title":"Tumors Exposed to Acute Cyclic Hypoxic Stress Show Enhanced Angiogenesis, Perfusion and Metastatic Dissemination","volume":"127","author":"Rofstad","year":"2010","journal-title":"Int J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00286","article-title":"Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer","volume":"7","author":"Iommarini","year":"2017","journal-title":"Front Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13578-017-0190-2","article-title":"Overexpression of Hypoxia-Inducible Factor and Metabolic Pathways: Possible Targets of Cancer","volume":"7","author":"Singh","year":"2017","journal-title":"Cell Biosci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161025536","article-title":"Cell Death Conversion Under Hypoxic Condition in Tumor Development and Therapy","volume":"16","author":"Qiu","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-11-0065","article-title":"Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression","volume":"9","author":"Welford","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01659-y","article-title":"The ER Stress Response Mediator ERO1 Triggers Cancer Metastasis by Favoring the Angiogenic Switch in Hypoxic Conditions","volume":"40","author":"Varone","year":"2021","journal-title":"Oncogene"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-Inducible Factor 1 Is a Basic-Helix-Loop-Helix-PAS Heterodimer Regulated by Cellular O2 Tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01168-1","article-title":"Signal Transduction to Hypoxia-Inducible Factor 1","volume":"64","author":"Semenza","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.05.010","article-title":"Hypoxia Up-Regulates the Effects of Prostaglandin E 2 on Tumor Angiogenesis in Ovarian Cancer Cells","volume":"94","author":"Zhu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1381-9","article-title":"Reduction of Hypoxia-Induced Angiogenesis in Ovarian Cancer Cells by Inhibition of HIF-1 Alpha Gene Expression","volume":"282","author":"Bryant","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0365","article-title":"Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells","volume":"146","author":"Yeung","year":"2005","journal-title":"Endocrinology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq127","article-title":"Stanniocalcin 1 and Ovarian Tumorigenesis","volume":"102","author":"Liu","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2009.09.018","article-title":"Stanniocalcin-2 Is a HIF-1 Target Gene That Promotes Cell Proliferation in Hypoxia","volume":"316","author":"Law","year":"2010","journal-title":"Exp Cell Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S196150","article-title":"Stanniocalcin 1 in Tumor Microenvironment Promotes Metastasis of Ovarian Cancer","volume":"12","author":"Yang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.06.026","article-title":"Stanniocalcin-2 Promotes Epithelial-Mesenchymal Transition and Invasiveness in Hypoxic Human Ovarian Cancer Cells","volume":"316","author":"Law","year":"2010","journal-title":"Exp Cell Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000300","article-title":"Estrogen and Progestin Regulate HIF-1\u03b1 Expression in Ovarian Cancer Cell Lines via the Activation of Akt Signaling Transduction Pathway","volume":"21","author":"Hua","year":"2009","journal-title":"Oncol Rep"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-335","article-title":"Prognostic Significance of Hypoxia-Inducible Factor 1 Alpha(HIF-1alpha) Expression in Serous Ovarian Cancer: An Immunohistochemical Study","volume":"8","author":"Daponte","year":"2008","journal-title":"BMC Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.02.010","article-title":"Expression of Hypoxia-Inducible Factor 1\u03b1, Hypoxia-Inducible Factor 2\u03b1, and Von Hippel-Lindau Protein in Epithelial Ovarian Neoplasms and Allelic Loss of Von Hippel-Lindau Gene: Nuclear Expression of Hypoxia-Inducible Factor 1\u03b1 Is an Independent Prognostic Factor in Ovarian Carcinoma","volume":"38","author":"Osada","year":"2007","journal-title":"Hum Pathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-0724","article-title":"Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction","volume":"26","author":"Das","year":"2008","journal-title":"Stem Cells"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer Stem Cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1593\/neo.13662","article-title":"Marker-Independent Method for Isolating Slow-Dividing Cancer Stem Cells in Human Glioblastoma","volume":"15","author":"Richichi","year":"2013","journal-title":"Neoplasia (United States)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.03.011","article-title":"Stem Cells and Cancer: Two Faces of Eve","volume":"124","author":"Clarke","year":"2006","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12693","article-title":"Drug Resistance and Cancer Stem Cells: The Shared But Distinct Roles of Hypoxia-Inducible Factors HIF1\u03b1 and HIF2\u03b1","volume":"44","author":"Sch\u00f6ning","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B100","first-page":"e1001","article-title":"Stem Cells in Ovarian Cancer and Potential Therapies","volume":"8","author":"Zuber","year":"2020","journal-title":"Proc Stem Cell Res Oncog"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.08.001","article-title":"Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells","volume":"5","author":"Yoshida","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110623","article-title":"Hypoxia-Mediated Cancer Stem Cell Resistance and Targeted Therapy","volume":"130","author":"Sun","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B103","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting Cancer Stem Cells by Inhibiting Wnt, Notch, and Hedgehog Pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10954","article-title":"Hypoxia-NOTCH1-SOX2 Signaling Is Important for Maintaining Cancer Stem Cells in Ovarian Cancer","volume":"7","author":"Seo","year":"2016","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-201","article-title":"The Hypoxic Microenvironment Upgrades Stem-Like Properties of Ovarian Cancer Cells","volume":"12","author":"Liang","year":"2012","journal-title":"BMC Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1 \u03b1 and HIF2 \u03b1: Sibling Rivalry in Hypoxic Tumour Growth and Progression","volume":"12","author":"Keith","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1038\/s41598-017-09244-8","article-title":"Hypoxia-Inducible Factor 1 Alpha Promotes Cancer Stem Cells-Like Properties in Human Ovarian Cancer Cells by Upregulating SIRT1 Expression","volume":"7","author":"Qin","year":"2017","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of Transcoelomic Metastasis in Ovarian Cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249492","article-title":"Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo-and Immunotherapies","volume":"21","author":"Klemba","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the Tumor Immune Microenvironment (TIME) for Effective Therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093125","article-title":"The Ovarian Cancer Tumor Immune Microenvironment (Time) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors","volume":"21","author":"Baci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00024","article-title":"The Unique Molecular and Cellular Microenvironment of Ovarian Cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090302","article-title":"Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment","volume":"10","author":"Drakes","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32990","article-title":"Metabolic Factors Contribute to T-Cell Inhibition in the Ovarian Cancer Ascites","volume":"147","author":"Gong","year":"2020","journal-title":"Int J Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e1535730","DOI":"10.1080\/2162402X.2018.1535730","article-title":"Immune Profiling and Identification of Prognostic Immune-Related Risk Factors in Human Ovarian Cancer","volume":"8","author":"R\u00e5destad","year":"2019","journal-title":"Oncoimmunology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 Regulates Function and Differentiation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"B117","article-title":"Constitutive Expression of TGF-B\u00eata1, Interleukin-6 and Interleukin-8 by Tumor Cells as a Major Component of Immune Escape in Human Ovarian Carcinoma","volume":"14","author":"Toutirais","year":"2003","journal-title":"Eur Cytokine Netw"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms Regulating the Recruitment of Macrophages Into Hypoxic Areas of Tumors and Other Ischemic Tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 Macrophages: Oracles of Health and Disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic Significance of Tumor-Associated Macrophages in Ovarian Cancer: A Meta-Analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12109","article-title":"The Role of Macrophages Polarization in Predicting Prognosis of Radically Resected Gastric Cancer Patients","volume":"17","author":"Pantano","year":"2013","journal-title":"J Cell Mol Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12409","article-title":"Hypoxia-Induced CCL28 Promotes Recruitment of Regulatory T Cells and Tumor Growth in Liver Cancer","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0570-x","article-title":"Possible Involvement of Regulatory T Cells in Tumor Onset and Progression in Primary Breast Cancer","volume":"58","author":"Ohara","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes and a High CD8+\/regulatory T Cell Ratio are Associated With Favorable Prognosis in Ovarian Cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22761","article-title":"Hypoxia Affects Dendritic Cell Survival: Role of the Hypoxia-Inducible Factor-1\u03b1 and Lipopolysaccharide","volume":"227","author":"Naldini","year":"2012","journal-title":"J Cell Physiol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-018-21891-z","article-title":"HIF-1\u03b1 Hampers Dendritic Cell Function and Th1 Generation During Chronic Visceral Leishmaniasis","volume":"8","author":"Hammami","year":"2018","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanniocalcin 1 Is a Phagocytosis Checkpoint Driving Tumor Immune Resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e0241932","DOI":"10.1371\/journal.pone.0241932","article-title":"Effects of Stanniocalcin-1 Overexpressing Hepatocellular Carcinoma Cells on Macrophage Migration","volume":"15","author":"Leung","year":"2020","journal-title":"PloS One"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2009.41.12.103","article-title":"Hypoxia and Angiogenesis: Regulation of Hypoxia-Inducible Factors via Novel Binding Factors","volume":"41","author":"Chen","year":"2009","journal-title":"Exp Mol Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nature12477","article-title":"Signatures of Mutational Processes in Human Cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7150\/jca.20314","article-title":"Immune Cell Population in Ovarian Tumor Microenvironment","volume":"8","author":"Cai","year":"2017","journal-title":"J Cancer"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.12.010","article-title":"Tumor-Associated Macrophages and the Tumor Immune Microenvironment of Primary and Recurrent Epithelial Ovarian Cancer","volume":"74","author":"Ojalvo","year":"2018","journal-title":"Hum Pathol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e173290","DOI":"10.1001\/jamaoncol.2017.3290","article-title":"Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer","volume":"3","author":"Goode","year":"2017","journal-title":"JAMA Oncol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02667-4","article-title":"Hypoxia and the Phenomenon of Immune Exclusion","volume":"19","author":"Pietrobon","year":"2021","journal-title":"J Transl Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3397","article-title":"Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer","volume":"33","author":"Hamanishi","year":"2015","journal-title":"J Clin Oncol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122927","article-title":"Ovarian Cancer Immunotherapy: Turning Up the Heat","volume":"20","author":"Ghisoni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.09.006","article-title":"A Robust Immune System Conditions the Response to Abagovomab (Anti-Idiotypic Monoclonal Antibody Mimicking the CA125 Protein) Vaccination in Ovarian Cancer Patients","volume":"191","author":"Battaglia","year":"2017","journal-title":"Immunol Lett"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa020177","article-title":"Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"B139","article-title":"Influence of Hypoxia Inducible Factors on the Immune Microenvironment in Ovarian Cancer","volume":"34","author":"Duechler","year":"2014","journal-title":"Anticancer Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2657","article-title":"Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma","volume":"22","author":"B\u00f6hm","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B141","article-title":"Ovarian Cancer-Associated Ascites Demonstrates Altered Immune Environment: Implications for Antitumor Immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143388","article-title":"Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated With Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence","volume":"13","author":"Alharbi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic Extracellular Microenvironment and Cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-7756-4_16","article-title":"Hypoxia-Induced Extracellular Acidosis Increases P-Glycoprotein Activity and Chemoresistance in Tumors In Vivo via P38 Signaling Pathway","volume":"701","author":"Thews","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.7150\/jca.21125","article-title":"The Glycolytic Switch in Tumors: How Many Players Are Involved","volume":"8","author":"Yu","year":"2017","journal-title":"J Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: Upstream and Downstream of Cancer Metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.05.010","article-title":"Opportunities in Discovery and Delivery of Anticancer Drugs Targeting Mitochondria and Cancer Cell Metabolism","volume":"61","author":"Pathania","year":"2009","journal-title":"Adv Drug Delivery Rev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.7150\/thno.41792","article-title":"Up-Regulation of Hypoxia-Inducible Factor Antisense as a Novel Approach to Treat Ovarian Cancer","volume":"10","author":"Lu","year":"2020","journal-title":"Theranostics"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2018.8514","article-title":"HIF-1\u03b1-Induced Autophagy Contributes to Cisplatin Resistance in Ovarian Cancer Cells","volume":"73","author":"Long","year":"2018","journal-title":"Pharmazie"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and Chemotherapy Resistance: A Promising Therapeutic Target for Cancer Treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells","volume":"289","author":"Wang","year":"2014","journal-title":"J Biol Chem"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15348","article-title":"Expression, Function and Clinical Application of Stanniocalcin-1 in Cancer","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1423-0127-18-39","article-title":"Stanniocalcin-1 Promotes Tumor Angiogenesis Through Up-Regulation of VEGF in Gastric Cancer Cells","volume":"18","author":"He","year":"2011","journal-title":"J BioMed Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-014-9668-z","article-title":"Stanniocalcin-1 Promotes Metastasis in a Human Breast Cancer Cell Line Through Activation of PI3K","volume":"31","author":"Murai","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4977","article-title":"Elevated STC-1 Augments the Invasiveness of Triple-Negative Breast Cancer Cells Through Activation of the JNK\/c-Jun Signaling Pathway","volume":"36","author":"Han","year":"2016","journal-title":"Oncol Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10585-014-9687-9","article-title":"STC1 Expression Is Associated With Tumor Growth and Metastasis in Breast Cancer","volume":"32","author":"Chang","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.9.7658","article-title":"Dynamic Regulation of Mouse Ovarian Stanniocalcin Expression During Gestation and Lactation","volume":"141","author":"Deol","year":"2000","journal-title":"Endocrinology"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00428-8","article-title":"MicroRNA Pathways in Flies and Worms: Growth, Death, Fat, Stress, and Timing","volume":"113","author":"Ambros","year":"2003","journal-title":"Cell"},{"key":"B159","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0092-8674(03)00231-9","article-title":"Bantam Encodes a Developmentally Regulated microRNA That Controls Cell Proliferation and Regulates the Proapoptotic Gene Hid in Drosophila","volume":"113","author":"Brennecke","year":"2003","journal-title":"Cell"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/35002607","article-title":"The 21-Nucleotide Let-7 RNA Regulates Developmental Timing in Caenorhabditis Elegans","volume":"403","author":"Reinhart","year":"2000","journal-title":"Nature"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0203","article-title":"MicroRNAs in Ovarian Carcinomas","volume":"17","author":"Dahiya","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.01.006","article-title":"Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer","volume":"12","author":"Pandey","year":"2019","journal-title":"Transl Oncol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041826","article-title":"Sevoflurane and Desflurane Exposure Enhanced Cell Proliferation and Migration in Ovarian Cancer Cells via Mir-210 and Mir-138 Downregulation","volume":"22","author":"Ishikawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2368","article-title":"Hypoxia-Induced miR-210 in Epithelial Ovarian Cancer Enhances Cancer Cell Viability via Promoting Proliferation and Inhibiting Apoptosis","volume":"45","author":"Li","year":"2014","journal-title":"Int J Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.2.5297","article-title":"miR-210 Links Hypoxia With Cell Cycle Regulation and Is Deleted in Human Epithelial Ovarian Cancer","volume":"7","author":"Giannakakis","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20192457","article-title":"Hypoxia-Induced Up-Regulation of miR-27a Promotes Paclitaxel Resistance in Ovarian Cancer","volume":"40","author":"Feng","year":"2020","journal-title":"Biosci Rep"},{"key":"B167","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages Derived Exosomes Deliver miR-223 to Epithelial Ovarian Cancer Cells to Elicit a Chemoresistant Phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F","article-title":"Expression of Hypoxia-Inducible Factor 1\u03b1 in Epithelial Ovarian Tumors: Its Impact on Prognosis and on Response to Chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/srep26191","article-title":"Assessing Mutant P53 in Primary High-Grade Serous Ovarian Cancer Using Immunohistochemistry and Massively Parallel Sequencing","volume":"6","author":"Cole","year":"2016","journal-title":"Sci Rep"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2825","article-title":"Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus","volume":"66","author":"Del Bufalo","year":"2006","journal-title":"Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3093","article-title":"Antitumor Effect of a Selective COX-2 Inhibitor, Celecoxib, May be Attributed to Angiogenesis Inhibition Through Modulating the PTEN\/PI3K\/Akt\/HIF-1 Pathway in an H22 Murine Hepatocarcinoma Model","volume":"31","author":"Sui","year":"2014","journal-title":"Oncol Rep"},{"key":"B172","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neo.2014.12.008","article-title":"Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis Through C-MYC and HIF-1\u03b1 in EGFR-Mutated Lung Cancer In Vitro and In Vivo","volume":"17","author":"Lee","year":"2015","journal-title":"Neoplasia (United States)"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-520","article-title":"Comparative Analysis of Novel and Conventional Hsp90 Inhibitors on HIF Activity and Angiogenic Potential in Clear Cell Renal Cell Carcinoma: Implications for Clinical Evaluation","volume":"11","author":"Bohonowych","year":"2011","journal-title":"BMC Cancer"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0682","article-title":"Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1\u03b1 in Advanced Solid Tumors","volume":"17","author":"Kummar","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 Inhibits Tumor Growth and Angiogenesis by Disrupting Microtubules and Dysregulating HIF","volume":"3","author":"Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1586\/era.10.226","article-title":"HER2-Amplified Breast Cancer: Mechanisms of Trastuzumab Resistance and Novel Targeted Therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN Activation Contributes to Tumor Inhibition by Trastuzumab, and Loss of PTEN Predicts Trastuzumab Resistance in Patients","volume":"6","author":"Nagata","year":"2004","journal-title":"Cancer Cell"},{"key":"B178","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4161\/cc.4.1.1360","article-title":"HER2-Targeting Antibodies Modulate the Cyclin-Dependent Kinase Inhibitor p27Kip1","volume":"4","author":"Le","year":"2005","journal-title":"via multiple Signaling pathways Cell Cycle"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0754","article-title":"Herceptin Sensitizes ErbB2-Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression","volume":"12","author":"Henson","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/mcb.21.12.3995-4004.2001","article-title":"HER2 (Neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1\u03b1 (HIF-1\u03b1) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/416279b","article-title":"Herceptin Acts as an Anti-Angiogenic Cocktail","volume":"416","author":"Izumi","year":"2002","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11656","article-title":"Combined Trastuzumab and Paclitaxel Treatment Better Inhibits ErbB-2-Mediated Angiogenesis in Breast Carcinoma Through a More Effective Inhibition of Akt Than Either Treatment Alone","volume":"98","author":"Klos","year":"2003","journal-title":"Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.9969","article-title":"DNA Amplification of HER-2\/Neu and INT-2 Oncogenes in Epithelial Ovarian Cancer","volume":"59","author":"Medl","year":"1995","journal-title":"Gynecol Oncol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.104","article-title":"Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group","volume":"21","author":"Bookman","year":"2003","journal-title":"J Clin Oncol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3852","article-title":"Targeting Stanniocalcin-1-Expressing Tumor Cells Elicits Efficient Antitumor Effects in a Mouse Model of Human Lung Cancer","volume":"10","author":"Abe","year":"2021","journal-title":"Cancer Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25214888","article-title":"Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic But Not Anoxic Cytotoxicity","volume":"25","author":"Guise","year":"2020","journal-title":"Molecules"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1039\/c9bm01905g","article-title":"Enhanced Selectivity, Cellular Uptake, and: In Vitro Activity of an Intrinsically Fluorescent Copper-Tirapazamine Nanocomplex for Hypoxia Targeted Therapy in Prostate Cancer","volume":"8","author":"Silva","year":"2020","journal-title":"Biomater Sci"},{"key":"B188","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00280-009-1188-1","article-title":"A Phase I Trial of PR-104, a Nitrogen Mustard Prodrug Activated by Both Hypoxia and Aldo-Keto Reductase 1C3, in Patients With Solid Tumors","volume":"65","author":"Jameson","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1039\/c9bm01640f","article-title":"Tirapazamine-Embedded Polyplatinum(Iv) Complex: A Prodrug Combo for Hypoxia-Activated Synergistic Chemotherapy","volume":"8","author":"Guo","year":"2020","journal-title":"Biomater Sci"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0018","article-title":"TH-302 in Combination With Radiotherapy Enhances the Therapeutic Outcome and Is Associated With Pretreatment [18F]HX4 Hypoxia PET Imaging","volume":"21","author":"Peeters","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3256-2","article-title":"Phase I Study of Pazopanib Plus TH-302 in Advanced Solid Tumors","volume":"79","author":"Riedel","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1671-3","article-title":"PR-104 Plus Sorafenib in Patients With Advanced Hepatocellular Carcinoma","volume":"68","author":"Abou-Alfa","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2015.1017171","article-title":"Pre-Clinical Activity of PR-104 as Monotherapy and in Combination With Sorafenib in Hepatocellular Carcinoma","volume":"16","author":"Abbattista","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the Folate Receptor \u03b1 in Oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119237","article-title":"Hypoxia-Responsive Folic Acid Conjugated Glycol Chitosan Nanoparticle for Enhanced Tumor Targeting Treatment","volume":"580","author":"Jang","year":"2020","journal-title":"Int J Pharm"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c01676","article-title":"Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy With 5-Fluorouracil for Colorectal Cancer and Liver Metastasis","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2017.11.010","article-title":"Chemo-Biologic Combinatorial Drug Delivery Using Folate Receptor-Targeted Dendrimer Nanoparticles for Lung Cancer Treatment","volume":"14","author":"Amreddy","year":"2018","journal-title":"Nanomed Nanotechnology Biol Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102228","article-title":"Folate Targeted Lipid Chitosan Hybrid Nanoparticles for Enhanced Anti-Tumor Efficacy","volume":"28","author":"Khan","year":"2020","journal-title":"Nanomed Nanotechnology Biol Med"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050738","article-title":"Gold Nanoparticles Affect Pericyte Biology and Capillary Tube Formation","volume":"13","author":"Looprasertkul","year":"2021","journal-title":"Pharmaceutics"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/20\/45\/455104","article-title":"Gold and Silver Nanoparticles Conjugated With Heparin Derivative Possess Anti-Angiogenesis Properties","volume":"20","author":"Kemp","year":"2009","journal-title":"Nanotechnology"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2013.1678","article-title":"Gold Nanoparticles Induce Nanostructural Reorganization of VEGFR2 to Repress Angiogenesis","volume":"9","author":"Pan","year":"2013","journal-title":"J\u00a0BioMed Nanotechnol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b12524","article-title":"Mesoporous Silica Nanoparticles as an Antitumoral-Angiogenesis Strategy","volume":"9","author":"Setyawati","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"B203","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.3390\/cancers13174444","article-title":"Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake","volume":"13","author":"Matuszewska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2015.010470","article-title":"Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer","volume":"12","author":"Chappell","year":"2016","journal-title":"J Oncol Pract"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S40527","article-title":"Bevacizumab in Combination With Chemotherapy in Platinum-Sensitive Ovarian Cancer","volume":"7","author":"Della Pepa","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx228","article-title":"Bevacizumab With or After Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: Exploratory Analyses of the AURELIA Trial","volume":"28","author":"Bamias","year":"2017","journal-title":"Ann Oncol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.01.037","article-title":"Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (Fr\u03b1)-Targeting Antibody-Drug Conjugate (ADC), in Combination With Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer","volume":"157","author":"O\u2019Malley","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-4183","article-title":"Kerbel RS. A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs","volume":"73","author":"Guerin","year":"2013","journal-title":"Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30349-8","article-title":"Apatinib Combined With Oral Etoposide in Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer (AEROC): A Phase 2, Single-Arm, Prospective Study","volume":"19","author":"Lan","year":"2018","journal-title":"Lancet Oncol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"eaak9679","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined Antiangiogenic and Anti-PD-L1 Therapy Stimulates Tumor Immunity Through HEV Formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci Transl Med"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13551","article-title":"FDA Approval Summary: Olaparib Monotherapy or in Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced Ovarian Cancer","volume":"26","author":"Arora","year":"2021","journal-title":"Oncologist"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.204896","article-title":"Resistance to Bevacizumab in Ovarian Cancer SKOV3 Xenograft Due to EphB4 Overexpression","volume":"15","author":"Li","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0719-6","article-title":"Cell-Free DNA Analysis Reveals POLR1D-Mediated Resistance to Bevacizumab in Colorectal Cancer","volume":"12","author":"Zhou","year":"2020","journal-title":"Genome Med"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-261636","article-title":"Combined Therapy With Thrombospondin-1 Type I Repeats (3TSR) and Chemotherapy Induces Regression and Significantly Improves Survival in a Preclinical Model of Advanced Stage Epithelial Ovarian Cancer","volume":"29","author":"Russell","year":"2015","journal-title":"FASEB J"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0220","article-title":"Combining Vascular Normalization With an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer","volume":"25","author":"Matuszewska","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.049","article-title":"Anti-Angiogenesis Effect of Neferine via Regulating Autophagy and Polarization of Tumor-Associated Macrophages in High-Grade Serous Ovarian Carcinoma","volume":"432","author":"Zhang","year":"2018","journal-title":"Cancer Lett"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-8-8","article-title":"The CNS Microvascular Pericyte: Pericyte-Astrocyte Crosstalk in the Regulation of Tissue Survival","volume":"8","author":"Bonkowski","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300752","article-title":"Rapid Estrogen Receptor Signaling Mediates Estrogen-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation","volume":"33","author":"Ueda","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000085560.02979.0C","article-title":"Hormone Replacement Therapy and Inflammation: Interactions in Cardiovascular Disease. in","volume":"42","author":"Miller","year":"2003","journal-title":"Hypertension"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308791","article-title":"Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis","volume":"37","author":"Johnson","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-Inducible Factor-1 Modulates Gene Expression in Solid Tumors and Influences Both Angiogenesis and Tumor Growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.772349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T12:43:57Z","timestamp":1673786637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.772349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":221,"alternative-id":["10.3389\/fendo.2021.772349"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.772349","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"article-number":"772349"}}